Rend Al-Mondhiry, a partner with the firm Amin Talati Wasserman, emphasized that the FDA’s pledge not to enforce rests upon the apparent safety of the ingredient.
Read the full article here
5185 MacArthur Blvd NW
Suite 230
Washington, D.C. 20016
PH:202.496.4966
515 South Flower Street
18th Floor
Los Angeles, CA 90071
PH:213.933.2330
The content in the Amin Wasserman Gurnani web site may constitute attorney advertising or advertising material within the meaning of applicable bar rules, and/or under the Rules of Professional Conduct governing lawyers. Nothing in this site is to be considered as either creating an attorney-client relationship between the reader and Amin Wasserman Gurnani or as the rendering of legal advice for any specific matter.
